< Terug naar vorige pagina
Octrooi
A novel human respiratory syncytial virus strain and its use
The present invention is directed to a novel isolated respiratory syncytial virus (RSV) strain. Also an immunogenic composition comprising said novel RSV strain is disclosed. Further, the present application is directed to said RSV strain or the immunogenic composition comprising said strain for use in the generation of an immune response against RSV in a subject. Also their use in the diagnosis of an RSV-associated diseases is disclosed.
Octrooi-publicatienummer: EP4031171
Jaar aanvraag: 2020
Jaar toekenning: 2023
Jaar van publicatie: 2022
Status: Aangevraagd
URI: link to Espacenet
Technologiedomeinen: undefined
Gevalideerd voor IOF-sleutel: Ja
Toegewezen aan: Associatie Universiteit & Hogescholen Antwerpen